Clinical and Experimental Reproductive Medicine

The Korean Society for Reproductive Medicine (대한생식의학회)
권호 표지
DOI QR코드

DOI QR Code

Endometrial fluid associated with Essure implants placed before in vitro fertilization: Considerations for patient counseling and surgical management

  • Sills, E Scott (Reproductive Research Section, Center for Advanced Genetics) ;
  • Walsh, David J (Division of Reproductive Endocrinology, Sims IVF/The Sims Institute) ;
  • Jones, Christopher A (Global Health Economics Unit, Vermont Center for Clinical and Translational Science, University of Vermont, College of Medicine) ;
  • Wood, Samuel H (Progenesis)
  • Received : 2015.06.24
  • Accepted : 2015.08.07
  • Published : 2015.09.30
Download PDF
⟨ Previous Next ⟩

Abstract

Essure (Bayer) received approval from the U.S. Food and Drugs Administration as a permanent non-hormonal contraceptive implant in November 2002. While the use of Essure in the management of hydrosalpinx prior to in vitro fertilization (IVF) remains off-label, it has been used specifically for this purpose since at least 2007. Although most published reports on Essure placement before IVF have been reassuring, clinical experience remains limited, and no randomized studies have demonstrated the safety or efficacy of Essure in this context. In fact, no published guidelines deal with patient selection or counseling regarding the Essure procedure specifically in the context of IVF. Although Essure is an irreversible birth control option, some patients request the surgical removal of the implants for various reasons. While these patients could eventually undergo hysterectomy, at present no standardized technique exists for simple Essure removal with conservation of the uterus. This article emphasizes new aspects of the Essure procedure, as we describe the first known association between the placement of Essure implants and the subsequent development of fluid within the uterine cavity, which resolved after the surgical removal of both devices.

Keywords

References

  1. Mahmoud MS, Fridman D, Merhi ZO. Subserosal misplacement of Essure device manifested by late-onset acute pelvic pain. Fertil Steril 2009;92:2038.e1-3.
  2. Belotte J, Shavell VI, Awonuga AO, Diamond MP, Berman JM, Yancy AF. Small bowel obstruction subsequent to Essure microinsert sterilization: a case report. Fertil Steril 2011;96:e4-6. https://doi.org/10.1016/j.fertnstert.2011.04.055
  3. Albright CM, Frishman GN, Bhagavath B. Surgical aspects of removal of Essure microinsert. Contraception 2013;88:334-6. https://doi.org/10.1016/j.contraception.2012.11.020
  4. He RH, Gao HJ, Li YQ, Zhu XM. The associated factors to endometrial cavity fluid and the relevant impact on the IVF-ET outcome. Reprod Biol Endocrinol 2010;8:46. https://doi.org/10.1186/1477-7827-8-46
  5. Matorras R, Rabanal A, Prieto B, Diez S, Brouard I, Mendoza R, et al. Hysteroscopic hydrosalpinx occlusion with Essure device in IVF patients when salpingectomy or laparoscopy is contraindicated. Eur J Obstet Gynecol Reprod Biol 2013;169:54-9. https://doi.org/10.1016/j.ejogrb.2013.02.008
  6. Thebault N, Broux PL, Moy L, Vialard J. Utilization of $Essure^{(R)}$ micro-insert for hydrosalpinx occlusion in infertile women. J Gynecol Obstet Biol Reprod (Paris) 2012;41:145-50. https://doi.org/10.1016/j.jgyn.2011.12.003
  7. Mijatovic V, Veersema S, Emanuel MH, Schats R, Hompes PG. Essure hysteroscopic tubal occlusion device for the treatment of hydrosalpinx prior to in vitro fertilization-embryo transfer in patients with a contraindication for laparoscopy. Fertil Steril 2010; 93:1338-42. https://doi.org/10.1016/j.fertnstert.2008.11.022
  8. Sills ES, Li X, Jones CA, Wood SH. Contraceptive failure after hysteroscopic sterilization: analysis of clinical and demographic data from 103 unplanned pregnancies. Obstet Gynecol Sci 2015. In press.
  9. Westerhoff P, Prapaipong P, Shock E, Hillaireau A. Antimony leaching from polyethylene terephthalate (PET) plastic used for bottled drinking water. Water Res 2008;42:551-6. https://doi.org/10.1016/j.watres.2007.07.048
  10. Cheng X, Shi H, Adams CD, Ma Y. Assessment of metal contaminations leaching out from recycling plastic bottles upon treatments. Environ Sci Pollut Res Int 2010;17:1323-30. https://doi.org/10.1007/s11356-010-0312-4

Cited by

  1. Combined hysteroscopy-laparoscopy approach for excision of pelvic nitinol fragment from Essure contraceptive device: Role of intraoperative fluoroscopy for uterine conservation vol.59, pp.4, 2015, https://doi.org/10.5468/ogs.2016.59.4.337
  2. Journal Editorial Board vol.48, pp.5, 2015, https://doi.org/10.1002/uog.15720
  3. High miscarriage rate in women treated with Essure® for hydrosalpinx before embryo transfer: a systematic review and meta‐analysis vol.48, pp.5, 2015, https://doi.org/10.1002/uog.15960
  4. Safety and patients’ satisfaction after hysteroscopic sterilisation vol.38, pp.3, 2018, https://doi.org/10.1080/01443615.2017.1362549